加纳慢性乙型肝炎治疗与护理障碍:对乙型肝炎患者和医护人员的定性研究
加纳慢性乙型肝炎治疗与护理障碍的定性研究数据集,包含患者和医护人员的访谈及焦点小组转录文本。

基本信息
资源简介
加纳慢性乙型肝炎治疗与护理障碍:对乙型肝炎患者和医护人员的定性研究
【数据集背景】
本数据集源站标题为《Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers》。配套论文《Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers》发表于 PLOS ONE(2019),DOI:10.1371/journal.pone.0225830。源站首次发布:2019-12-03。
【数据内容】
源站原始描述:Background Hepatitis B viral (HBV) infection remains an important public health concern particularly in Africa. Between 1990 and 2013, Hepatitis B mortality increased by 63%. In recent times, effective antiviral agents against HBV such as Nucleos(t)ide analogs (NAs) are available. These drugs are capable of suppressing HBV replication, preventing progression of chronic Hepatitis B to cirrhosis, and reducing the risk of hepatocellular carcinoma and liver-related death. Notwithstanding, these trea…
【数据结构与技术规格】
文件数 3 个,合计 43.39 KB。pone.0225830.s001.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,14.68 KB。pone.0225830.s002.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,14.31 KB。pone.0225830.s003.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,14.40 KB。数据集 DOI:10.1371/journal.pone.0225830。
【主题与分类】
源站学科分类:Medicine、Biotechnology、Cancer、Science Policy、Infectious Diseases。主题标签:HBV、FGD、15 healthcare providers、NHIS、QSR Nvivo version 10.0、HCP、health system-related barriers、healthcare providers Background Hepatitis B、NA、Hepatitis B education。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/Barriers_to_chronic_Hepatitis_B_treatment_and_care_in_Ghana_A_qualitative_study_with_people_with_Hepatitis_B_and_healthcare_providers/11311550
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Adjei, Charles Ampong; Stutterheim, Sarah E.; Naab, Florence; Ruiter, Robert A. C. (2019). Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers. PLOS ONE. Dataset
【使用注意】
· 源站最后修改于 2023-05-30,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers
- DOI:10.1371/journal.pone.0225830
- 发布日期:2019-12-03
- 文件数:3 个
- 文件总体积:43.39 KB
- 源站页面:https://plos.figshare.com/articles/dataset/Barriers_to_chronic_Hepatitis_B_treatment_and_care_in_Ghana_A_qualitative_study_with_people_with_Hepatitis_B_and_healthcare_providers/11311550
命令行下载
curl -L -o "pone.0225830.s001.docx" "https://ndownloader.figshare.com/files/20048648"
curl -L -o "pone.0225830.s002.docx" "https://ndownloader.figshare.com/files/20048651"
curl -L -o "pone.0225830.s003.docx" "https://ndownloader.figshare.com/files/20048654"
文件清单
pone.0225830.s001.docx(14.68 KB)pone.0225830.s002.docx(14.31 KB)pone.0225830.s003.docx(14.40 KB)
文件总体积 43.39 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Background
Hepatitis B viral (HBV) infection remains an important public health concern particularly in Africa. Between 1990 and 2013, Hepatitis B mortality increased by 63%. In recent times, effective antiviral agents against HBV such as Nucleos(t)ide analogs (NAs) are available. These drugs are capable of suppressing HBV replication, preventing progression of chronic Hepatitis B to cirrhosis, and reducing the risk of hepatocellular carcinoma and liver-related death. Notwithstanding, these treatments are underused despite their effectiveness in managing Hepatitis B. This study sought to explore barriers to treatment and care for people with Hepatitis B (PWHB) in Ghana, paying particular attention to beliefs about aetiology that can act as a barrier to care for PWHB.
Methods
We used an exploratory qualitative design with a purposive sampling technique. Face-to-face interviews were conducted for 18 persons with Hepatitis B (PWHB) and 15 healthcare providers (HCP; physicians, nurses, and midwives). In addition, four focus group discussions (FGD) with a composition of eight HCPs in each group were done. Participants were recruited from one tertiary and one regional hospital in Ghana. Data were processed using QSR Nvivo version 10.0 and analysed using the procedure of inductive thematic analysis. Participants were recruited from one tertiary and one regional hospital in Ghana.
Results
Three main cultural beliefs regarding the aetiology of chronic Hepatitis B that act as barriers to care and treatment were identified. These were: (1) the belief that chronic Hepatitis B is a punishment from the gods to those who touch dead bodies without permission from their landlords, (2) the belief that bewitchment contributes to chronic Hepatitis B, and (3) the belief that chronic Hepatitis B is caused by spiritual poison. Furthermore, individual level barriers were identified. These were the absence of chronic Hepatitis B signs and symptoms, perceived efficacy of traditional herbal medicine, and PWHB’s perception that formal care does not meet their expectations. Health system-related barriers included high cost of hospital-based care and inadequate Hepatitis B education for pati
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0225830(source: https://plos.figshare.com/articles/dataset/Barriers_to_chronic_Hepatitis_B_treatment_and_care_in_Ghana_A_qualitative_study_with_people_with_Hepatitis_B_and_healthcare_providers/11311550)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




